We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.36B
AUM Growth
+$353M
Cap. Flow
+$69.5M
Cap. Flow %
1.09%
Top 10 Hldgs %
13.3%
Holding
1,175
New
186
Increased
412
Reduced
363
Closed
161

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$25.8M
2
AMZN icon
Amazon
AMZN
+$22.7M
3
XLNX
Xilinx Inc
XLNX
+$20.3M
4
EG icon
Everest Group
EG
+$18.9M
5
LKQ icon
LKQ Corp
LKQ
+$16.2M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$36M
2
UNH icon
UnitedHealth
UNH
+$29.5M
3
MRK icon
Merck
MRK
+$17.8M
4
BAX icon
Baxter International
BAX
+$17.5M
5
AAPL icon
Apple
AAPL
+$17.2M

Sector Composition

Rank Sector Weight
1 Technology 19.46%
2 Financials 17.64%
3 Consumer Discretionary 12.58%
4 Industrials 12.01%
5 Healthcare 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAVB
1001
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$81K ﹤0.01%
17,660
-4,154
-19% -$21.7K
EPE
1002
DELISTED
EP Energy Corporation
EPE
$78K ﹤0.01%
26,100
+4,500
+21% +$10.7K
VATE icon
1003
INNOVATE Corp
VATE
$114M
$75K ﹤0.01%
+1,280
New +$75.2K
SB icon
1004
Safe Bulkers
SB
$781M
$72K ﹤0.01%
+21,212
New +$70.4K
BSQR
1005
DELISTED
BSQUARE Corporation
BSQR
$68K ﹤0.01%
+25,299
New +$94.4K
XFOR icon
1006
X4 Pharmaceuticals
XFOR
$363M
$42K ﹤0.01%
+64
New +$210K
SCYX icon
1007
SCYNEXIS
SCYX
$37M
$35K ﹤0.01%
264
-184
-41% -$21.9K
HIND
1008
Vyome Holdings
HIND
$14.5M
0
PLUR icon
1009
Pluri
PLUR
$19.2M
$22K ﹤0.01%
223
-80
-26% -$8.38K
ATNM icon
1010
Actinium Pharmaceuticals
ATNM
$27M
$18K ﹤0.01%
+953
New +$12.1K
CLDX icon
1011
Celldex Therapeutics
CLDX
$2.77B
$15K ﹤0.01%
1,933
-15,074
-89% -$201K
AGRX
1012
DELISTED
Agile Therapeutics
AGRX
$15K ﹤0.01%
16
RSYS
1013
DELISTED
Radisys Corp
RSYS
$14K ﹤0.01%
19,681
A icon
1014
Agilent Technologies
A
$39.1B
-4,600
Closed -$308K
ABG icon
1015
Asbury Automotive
ABG
$4.19B
-2,990
Closed -$202K
AEIS icon
1016
Advanced Energy
AEIS
$12.2B
-9,800
Closed -$626K
AGO icon
1017
Assured Guaranty
AGO
$3.78B
-6,190
Closed -$224K
AGYS icon
1018
Agilysys
AGYS
$2.78B
-15,951
Closed -$190K
AL
1019
DELISTED
Air Lease Corp
AL
-18,254
Closed -$778K
ASYS icon
1020
Amtech Systems
ASYS
$278M
-45,555
Closed -$333K
ATRC icon
1021
AtriCure
ATRC
$1.77B
-30,259
Closed -$621K
AVAV icon
1022
AeroVironment
AVAV
$7.57B
-89,789
Closed -$4.09M
AXP icon
1023
American Express
AXP
$223B
-42,330
Closed -$3.95M
BEN icon
1024
Franklin Resources
BEN
$16.9B
-22,880
Closed -$793K
BGC icon
1025
BGC Group
BGC
$5.58B
-141,972
Closed -$1.23M

Similar funds

Jacobs Levy Equity Management's Q2 2018 Portfolio in Review

As of Q2 2018, Jacobs Levy Equity Management held 1,175 positions worth $6.36B, up 5.9% from $6.01B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management's Q2 2018 filing shows 186 new, 412 increased, 363 reduced and 161 closed positions. Its largest new stake was LKQ Corp: 486,474 shares worth $15.5M. The largest sale was PepsiCo, an estimated $36M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q2 2018 buy was LKQ Corp: 486,474 shares worth $15.5M.
  • Jacobs Levy Equity Management added most to ConocoPhillips in Q2 2018, an estimated $25.8M increase.
  • Jacobs Levy Equity Management's biggest Q2 2018 reduction was PepsiCo, cutting an estimated $36M.
  • Jacobs Levy Equity Management fully exited General Dynamics in Q2 2018, selling an estimated $11M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.36B portfolio in Q2 2018.
  • Jacobs Levy Equity Management opened 186 new positions and closed 161 in Q2 2018.
  • Jacobs Levy Equity Management's portfolio value rose 5.9% quarter-over-quarter to $6.36B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.